top of page

Recent Posts

Which chemotherapy drugs have the highest cardiotoxicity risk in pediatric cancer?

OPACC
Apr 16, 2019
1 min read

A recent study published in JAMA Oncology analyzed data generated from over 28,000 childhood cancer survivors and compared the lifetime cardiotoxicity risk in different chemotherapeutic drugs used for treatment.

Read more: https://www.medicalnewsbulletin.com/chemotherapy-drugs-highest-cardiotoxicity-risk-pediatric-cancer/

Kommentare

Study Unveils Potential Therapeutic Pathways for Aggressive Pediatric Brain Tumor

Children and families in Northwestern Ontario facing childhood cancer now have access to comprehensive, specialized care in Thunder Bay

Young Cancer Survivors Struggle With Persistent Fear of Recurrence

Childhood kidney cancer has millions of genetic changes, opening door to possible treatments

Genetics and therapy type determine second cancer risk after childhood treatment

Potential new treatment to tackle commonest form of childhood cancer

Researchers discover new protein target for childhood medulloblastomas

Childhood Cancer Survivors at Increased Risk of CKD, Hypertension

Study reveals targetable mechanism behind high-risk predisposition gene in pediatric medulloblastoma

Duration of Overweight/Obesity During Treatment Linked to Worse Outcomes in Pediatric Leukemia Patients

Archive

Search By Tags

bottom of page